×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [6]
昆明动物研究所 [6]
中国医学科学院 北京... [4]
合肥物质科学研究院 [4]
计算技术研究所 [2]
寒区旱区环境与工程研... [2]
更多...
内容类型
期刊论文 [29]
学位论文 [3]
会议论文 [2]
发表日期
2022 [1]
2021 [4]
2019 [3]
2018 [3]
2017 [6]
2016 [4]
更多...
学科主题
细胞生物学 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共34条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
收藏
  |  
浏览/下载:92/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations
期刊论文
EBIOMEDICINE, 2021, 卷号: 69, 页码: 11
作者:
Yang, Mei
;
Fan, Yanhui
;
Wu, Zhi-Yong
;
Gu, Jin
;
Feng, Zhendong
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2021/12/01
HER2-negative breast cancer
Germline rare coding mutations
Damage assessment of genomic mutations (DAGM)
Risk assessment
Activity profiles of signalling pathways (APSP)
HER2 signalling pathway
Immune suppression
Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Wang, Rong
;
Wang, Xiaojia
;
Chen, Zhan-Hong
;
Niu, Jin
;
Huang, Yuan
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2022/01/10
Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer
期刊论文
CANCER RESEARCH, 2021, 卷号: 81, 期号: 4, 页码: 1
作者:
Yang, Mei
;
Fan, Yanhui
;
Wu, Zhi-Yong
;
Feng, Zhendong
;
Zhang, Qiangzu
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2021/12/01
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Tian, Yiping
;
Sun, Xiaohui
;
Cheng, Guoping
;
Ji, Enming
;
Yang, Shifeng
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2021/05/17
CMTM6
PD-L1
triple-negative breast cancer (TNBC)
immunohistochemistry (IHC)
polymerase chain reaction (PCR)
prognosis
The significance of Oncotype DX recurrence score in T1-2N1M0 ER positive HER2 negative breast cancer: An analysis combined with the prognostic stage in the updated AJCC 8th edition
会议论文
作者:
Zhang, M.
;
Chen, H.
;
Wang, M.
;
Zhang, P.
;
Wu, K.
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11, 页码: 3153-3162
作者:
Sun, Yi
;
Li, Wenqiang
;
Li, Ai-Jie
;
Su, Huichao
;
Yue, Jinbo
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/11
breast cancer
SII
HER2
inflammation
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
期刊论文
Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072
作者:
Y.Liu
;
Y.H.Zhou
;
K.H.Huang
;
Y.Li
;
X.J.Fang
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/08/24
triple-negative breast cancer,human epidermal growth factor receptor,chimeric antigen receptor engineered T cells,negative breast-cancer,growth-factor receptor,therapy,amplification,inhibition,expression,challenges,mutations,her2,Cell Biology,Geriatrics & Gerontology
YB-1通过上调KLF5基因转录促进三阴性乳腺癌细胞增殖
学位论文
北京: 中国科学院大学, 2018
作者:
彭俊讲
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2019/09/30
三阴性乳腺癌
Klf5
Yb-1
Dach1
Tnbc
EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer
期刊论文
Acta Biochimica et Biophysica Sinica, 2018, 卷号: 50, 期号: 7, 页码: 693–700
作者:
Qiuju Wu
;
Ceshi Chen
;
Rong Liu
;
You Peng
;
Wenhui Zhou
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2018/09/28
Mir-1301
Ezh2
Triple Negative Breast Cancer
©版权所有 ©2017 CSpace - Powered by
CSpace